BRIEF-Biotest regains rights to Tregalizumab (BT-061) By: Reuters: Company News June 24, 2015 at 03:18 AM EDT * AbbVie exercised its rights to opt-out of worldwide license, development and commercialisation agreement Read More >> Related Stocks: AbbVie Bio-Rad Laboratories